Navigation Links
Novel microfluidic HIV test is quick and cheap
Date:7/16/2010

UC Davis biomedical engineer Prof. Alexander Revzin has developed a "lab on a chip" device for HIV testing. Revzin's microfluidic device uses antibodies to "capture" white blood cells called T cells that are affected by HIV. In addition to physically binding these cells the test detects the types and levels of inflammatory proteins (cytokines) released by the cells.

Revzin's team collaborated with UCLA electrical engineer Prof. Aydogan Ozcan to integrate an antibody microarray with a lensfree holographic imaging device that takes only seconds to count the number of captured cells and amount of secreted cytokine molecules. The test returns results six to twelve times faster than traditional approaches and tests six parameters simultaneously, based on a small blood sample. The Revzin team published the results of their experiments in the May 2010 issue of Analytical Chemistry.

With further refinements, the test will have wide potential use for multi-parametric blood analysis performed at the point of care in the developing world and resource-poor areas. Its affordability will also make it an attractive option in wealthier areas. Revzin has filed for a patent and is looking for ways to bring his test into clinical use.

"In addition to HIV testing and monitoring, this device will be useful for blood transfusions, where the safety of blood is frequently in question," Revzin says.

The most accurate and effective way to diagnose and monitor HIV infection involves counting two types of T-cells, calculating the ratio between the two types of T-cells, and measuring cytokines. Scientists do this using a method called flow cytometry that requires an expensive machine and several highly trained specialists. Healthcare workers and AIDS activists in the developing world have called for less expensive, more easily performed tests.

"While the point of care field focuses on detection of single parameter (e.g. CD4 counts), we believe that the simplicity of the test need not compromise information content. So, we set out to develop a test that could be simple and inexpensive but would provide several parameters based on a single injection of a small blood volume," explains Revzin.

The HIV test addresses two distinct challenges of blood analysis: 1) capturing the desired cell type from blood, which contains multiple cell types, and 2) connecting the desired blood cell type with secreted cytokines. The test consists of polymer film imprinted with an array of miniature spots. Each spot contains antibodies specific to the two kinds of T-cells (CD4 and CD8) and three types of cytokines printed in the same array. When the blood flowed across the antibody spots, T cells stopped and stuck on the spots.

Each T-cell type was captured next to antibody spots specific for the cytokines they might produce. When antibodies activated the cells, spots adjacent to the cells captured the cytokines they secreted. This connected a specific T-cell subset to its secreted cytokines. The visible color intensity of antibody spots revealed differences in cytokine production by T-cells. Prof. Ozcan's lensfree on-chip imaging allowed the scientists to rapidly image and count T-cell arrays without the use of any lenses or mechanical scanning. Analysis of CD4 and CD8 T-cell numbers, the CD4/CD8 ratio and three secreted cytokines took only seconds.

In the future, Prof. Revzin envisions adding microarrays to the test that can detect proteins from the HIV and hepatitis C viruses.


'/>"/>

Contact: Holly Ober
hjober@ucdavis.edu
University of California - Davis - Health System
Source:Eurekalert  

Related biology news :

1. NIH-supported study finds novel pathway may open doors for new blood pressure treatments
2. Novel protein essential for successful pregnancy
3. UT Southwestern researchers use novel sperm stem-cell technique to produce genetically modified rats
4. Novel processing technologies developed for extending use of oats in gluten-free diet
5. Novel strategy for generating induced pluripotent stem cells for clinical use is safe and efficient
6. International research team discovers novel genes influencing kidney disease risk
7. Researchers use novel nanoparticle vaccine to cure type 1 diabetes in mice
8. Pitt-led international study identifies human enzyme that breaks down potentially toxic nanomaterials, opens door to novel drug delivery
9. OptiNoses novel intranasal sumatriptan product highly effective in treating migraines
10. UMMS researchers uncover novel genetic pathway responsible for triggering vascular growth
11. Novel Parkinsons treatment strategy involves cell transplantation
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Novel microfluidic HIV test is quick and cheap
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 /PRNewswire/ ... product subsidiary of Infosys (NYSE: INFY ), and ... global partnership that will provide end customers with ... banking and payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ... area for financial services, but it also plays a fundamental ...
(Date:4/19/2016)... DUBAI , UAE, April 20, 2016 ... can be implemented as a compact web-based "all-in-one" system ... in the biometric fingerprint reader or the door interface ... requirements of modern access control systems. The minimal dimensions ... the ID readers into the building installations offer considerable ...
(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
Breaking Biology News(10 mins):
(Date:5/23/2016)... Holly Springs, North Carolina (PRWEB) , ... May ... ... comprehensive process automation and building management solutions and services based in Aurora, Ohio, ... a decade of established business in the Research Triangle Park area, this new ...
(Date:5/22/2016)... (PRWEB) , ... May 22, 2016 , ... Doctors in ... in combating the asbestos cancer, malignant mesothelioma. Surviving Mesothelioma has just posted an article ... in the University of Rome’s Department of Clinical Sciences and Translational Medicine evaluated more ...
(Date:5/20/2016)... (PRWEB) , ... May 20, 2016 , ... Kablooe Design, ... goods companies, today announced its official 25th anniversary of the business. “We have worked ... so grateful to our customers for the privilege and honor of serving their product ...
(Date:5/20/2016)... ... ... The recent recall by Costco and Trader Joes of 47 million pounds of ... demonstrates the need for faster and more cost effective bio-threat detection to ensure food ... , PathSensor’s latest solution uses a biosensor technology called CANARY®. CANARY®, an ...
Breaking Biology Technology: